Phase 4 N=24 Fentanyl Patch Pharmacokinetics in Healthy Adults
Peer Review, Research
Primary: Area Under the Curve (AUC 0-∞ ) ng∙h/mL — 60.1; 64.2 ng∙h/mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=1,957 Moderate Acute Malnutrition (MAM) and Severe Acute Malnutrition (SAM) in Sierra Leone
Malnutrition
Primary: Recovery Under the Integrated Program and the Standard Protocol — 910; 682 Participants
Phase 2 N=16 LAM Pilot Study With Imatinib Mesylate
Lymphangioleiomyomatosis
Primary: Serum VEGF-D — 0.05; 0.07 Log transformed VEGF-D change pg/dL
Phase 4 N=1 PTC Study to Evaluate Ataluren in Combination With Ivacaftor
Cystic Fibrosis
Primary: FEV1 as a Measure of Lung Function — .35 percentage of liters
Phase 4 N=60 Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
Schizophrenia
Primary: Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) — 6.7; 0.9; 3.9; 5.9 T scores — p=<0.03
N/A N=216 Efficacy of Mental Health Self-Directed Care Financing
Mental Illness Persistent
Primary: Recovery From Mental Illness — 148.0; 152.81; 151.88; 154.56 score on a scale — p=<.01
N/A N=33 Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System
Post-Amputation Pain · Phantom Limb Pain · Residual Limb Pain
Primary: Proportion of Group 1 (Treatment) and Group 2 (Control) Subjects That Achieved ≥ 50% Reduction in All Qualifying Areas of Pain in the First 4 Weeks of Treatment — 7; 2…
N/A N=50 Immediate Loading Versus Delayed Loading in Single-implant
Immediate Dental Implant Loading
Primary: Change in Level of Marginal Bone — -0.57; -0.69 mm
N/A N=170 Real World Data on Management of Male LUTS
Benign Prostatic Hyperplasia
Primary: The Percentage of Men Given a Drug Prescription for Their Urinary Symptoms, as Recorded in Their Medical Records — 35.7 Percentage of participants
N/A N=187 GER Poses a Potential Risk for Late Complications of BPD
Gastroesophageal Reflux · Bronchopulmonary Dysplasia
Primary: the Late Complications of BPD Infants — 57; 45; 30; 4 Participants
Phase 2 N=18 Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
Seizures · Disorder of Fetus or Newborn
Primary: Drug Clearance — 0.71; 1.31 ml/min/kg
N/A N=80 Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis
Peritoneal Dialysis Associated Peritonitis
Primary: Complete Cure Rate — 32; 31 Participants
Phase 2 N=15 Topical NanoDox® for Atopic Dermatitis
Dermatitis, Atopic
Primary: Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0 — 0 Participants
N/A N=49 Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors
Survivorship · Fatigue
Primary: Feasibility of the Technology-enhanced Fitness Program — 25; 24 Participants
N/A N=27 PET/CT-Assessment of Liver Tumor Ablation
Liver Tumor · Liver Neoplasms
Primary: Number and Percentage of Tumors With Complete, Circumferential Ablation Margin Visibility During FDG PET/CT-guided Liver Ablations (AP-PET-1 v. Contrast-enhanced MRI)…